Zscan4 as a Candidate Conveyor of Early Developmental Defects in O-GlcNAc Transferase Intellectual Disability

Area of Science:

• Biochemistry
• Genetics
• Developmental Biology

Background:

• Variants in the human beta-N-acetylglucosamine (O-GlcNAc) transferase (OGT) gene cause OGT congenital disorder of glycosylation (OGT-CDG), a syndrome associated with intellectual disability.
• The underlying mechanisms of OGT-CDG, particularly concerning protein O-GlcNAcylation disruption and developmental origins, remain poorly understood.

Purpose of the Study:

• To investigate the molecular mechanisms of OGT-CDG by characterizing patient-derived mutations in mouse embryonic stem cells.
• To identify candidate proteins and pathways affected by OGT mutations, potentially explaining the syndrome's developmental aspects.

Main Methods:

• Establishment and characterization of two mouse embryonic stem cell lines with distinct patient mutations.
• Quantitative proteomics analysis of pluripotent stem cells to identify protein and pathway alterations.
• Assessment of O-GlcNAc homeostasis, OGT and OGA levels, and Zscan4/OGT:TET complex expression.

Main Results:

• Patient-derived mutations disrupt O-GlcNAc homeostasis, evidenced by altered OGT and OGA levels.
• Upregulation of the intellectual disability gene Zscan4 was observed in mutant cells.
• Increased levels of the OGT:TET protein complex, which regulates DNA methylation and Zscan4 expression, were identified.

Conclusions:

• Disrupted O-GlcNAc homeostasis and altered OGT:TET complex activity represent a potential mechanism contributing to the developmental deficits in OGT-CDG.
• This study provides novel insights into the molecular pathology of OGT-CDG, highlighting Zscan4 and DNA methylation regulation.
• Further research into the OGT:TET interaction could reveal therapeutic targets for OGT-CDG.